Corren J
Allergy Research Foundation, Inc., Los Angeles, CA 90025, USA.
J Allergy Clin Immunol. 1997 Feb;99(2):S781-6. doi: 10.1016/s0091-6749(97)70127-1.
Dysfunction of the upper and lower airways frequently coexist, and they appear to share key elements of pathogenesis. Data from epidemiologic studies indicate that nasal symptoms are experienced by as many as 78% of patients with asthma and that asthma is experienced by as many as 38% of patients with allergic rhinitis. Studies also have identified a temporal relation between the onset of rhinitis and asthma, with rhinitis frequently preceding the development of asthma. Patients with allergic rhinitis and no clinical evidence of asthma commonly exhibit nonspecific bronchial hyperresponsiveness. The observation that management of allergic rhinitis also relieves symptoms of asthma has heightened interest in the link between these diseases. Intranasal corticosteroids can prevent increases in nonspecific bronchial reactivity and asthma symptoms associated with seasonal pollen exposure. Similarly, among patients with perennial rhinitis, daily asthma symptoms, exercise-induced bronchospasm, and bronchial responsiveness to methacholine are reduced after administration of intranasal corticosteroids. Antihistamines, with or without decongestants, reduce seasonal rhinitis symptoms, asthma symptoms, and objective measurements of pulmonary function among patients with rhinitis and asthma. The mechanisms that connect upper and lower airway dysfunction are under investigation. They include a nasal-bronchial reflex, mouth breathing caused by nasal obstruction, and pulmonary aspiration of nasal contents. Nasal allergen challenge results in increases in lower airway reactivity within 30 minutes, suggesting a neural reflex. Improvements in asthma associated with increased nasal breathing may be the result of superior humidification, warming of inspired air, and decreased inhalation of airborne allergens. Postnasal drainage of inflammatory cells during sleep also may affect lower airway responsiveness. A link between allergic rhinitis and asthma is evident from epidemiologic, pathophysiologic, and clinical studies. Future research, however, is needed to determine whether nasal therapy can alter the natural history of asthma.
上、下气道功能障碍常常并存,且它们在发病机制上似乎有一些关键的共同要素。流行病学研究数据表明,高达78%的哮喘患者有鼻部症状,而高达38%的变应性鼻炎患者患有哮喘。研究还确定了鼻炎和哮喘发病之间的时间关系,鼻炎常常先于哮喘发生。没有哮喘临床证据的变应性鼻炎患者通常表现出非特异性支气管高反应性。变应性鼻炎的治疗也能缓解哮喘症状这一观察结果,引发了人们对这些疾病之间联系的更多关注。鼻用糖皮质激素可以预防与季节性花粉暴露相关的非特异性支气管反应性增加和哮喘症状。同样,在常年性鼻炎患者中,鼻用糖皮质激素给药后,每日哮喘症状以及运动诱发的支气管痉挛和对乙酰甲胆碱的支气管反应性均会降低。抗组胺药,无论是否加用减充血剂,均可减轻鼻炎和哮喘患者的季节性鼻炎症状、哮喘症状以及肺功能的客观指标。连接上、下气道功能障碍的机制正在研究中。这些机制包括鼻 - 支气管反射、鼻阻塞引起的口呼吸以及鼻腔内容物的肺内吸入。鼻内变应原激发可在30分钟内导致下气道反应性增加,提示存在神经反射。与鼻呼吸增加相关的哮喘改善可能是由于更好的空气湿化、吸入空气的加温以及空气中变应原吸入减少。睡眠期间炎性细胞的鼻后滴流也可能影响下气道反应性。变应性鼻炎和哮喘之间的联系在流行病学、病理生理学和临床研究中都很明显。然而,未来还需要开展研究以确定鼻部治疗是否能够改变哮喘的自然病程。